SAN CARLOS, Calif.--(BUSINESS WIRE)--Nektar Therapeutics (Nasdaq:NKTR) will announce its financial results for the third quarter 2006 on Thursday, November 2, 2006. On that day, Robert Chess, Nektar chairman of the board and acting president and chief executive officer, will host a conference call for analysts and investors beginning at 2:00 p.m. Pacific Time, to discuss further the Company’s performance.
